Ionis Pharmaceuticals | IONS - القيمة السوقية





القيمة السوقية تغيير تاريخ
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Arrowhead Research USD 8.78B 236M 2026-03
Astellas Pharma JPY 4.56T 770.92B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Divis Laboratories Ltd INR 1.58T 118.27B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 10.89B 857M 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 11.91B 11.05B 2026-06
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 307.76B 15.54B 2026-03
OPKO Health USD 967.3M 263.06M 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pfizer USD 153.81B 12.24B 2026-03
Pharma Mar EUR 1.57B 225M 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Qiagen NV USD 8.27B 1.62B 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.28B 30M 2026-03
Sartorius EUR 14.25B 2.16B 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03
Zealand Pharma A/S 33.35B 448.34M 2025-12